Cardlytics, INC 8-K filings

Cardlytics, Inc. announced its second quarter 2026 financial results, reporting a decrease in revenue and billings year-over-year, alongside a wider net loss, while also providing Q3 2026 guidance.

Cardlytics, Inc. has implemented a 1-for-10 reverse stock split and reduced authorized shares to address Nasdaq's minimum bid price requirement, with a compliance deadline of November 30, 2026.

Cardlytics, Inc. held its Annual Meeting on May 20, 2026, where shareholders elected directors, ratified the auditor, approved a potential reverse stock split, and voted on executive compensation.

Cardlytics, Inc. announced the resignation of its Chief Legal and Privacy Officer, Nick Lynton, with a transition agreement outlining severance and continued services.

Cardlytics, Inc. has completed the sale of its Bridg platform to PAR Technology Corporation, receiving 1,810,222 shares of PAR common stock as consideration.

Cardlytics announced its fourth quarter and full year 2025 financial results, showing mixed performance with revenue declines but improved adjusted profitability, alongside a challenging Q1 2026 outlook.

Cardlytics, Inc. has entered into an agreement to sell its Bridg platform to PAR Technology Corporation for up to $30 million in PAR common stock.

Cardlytics Inc. announced the appointment of company alumnus David Evans as its new Chief Financial Officer, effective January 12, 2026, replacing Alexis DeSieno.

Cardlytics, Inc. announced that Chief Financial Officer Alexis DeSieno will resign, effective by March 6, 2026, or upon the appointment of her successor.

Cardlytics reported a 22% year-over-year revenue decrease to $52.0 million in Q3 2025, alongside a positive Adjusted EBITDA of $3.2 million.

Cardlytics Inc. announced a significant workforce reduction of approximately 120 employees and contractors, representing 30% of its total workforce, as part of a broader cost-saving initiative targeting at least $26 million in annualized cash savings.

Cardlytics reported a 9% year-over-year revenue decrease to $63.2 million in Q2 2025, alongside a 19% increase in monthly qualified users.

Cardlytics, Inc. has extended its Master Agreement with JPMorgan Chase Bank, National Association until November 18, 2028, while also amending financial terms including a future reduction in Supplier Billings Share.

Cardlytics, Inc. has updated CEO Amit Gupta's compensation package, granting 1.2 million equity awards and enhancing severance benefits, as detailed in a recent SEC filing.

Cardlytics, Inc. stockholders approved the 2025 Equity Incentive Plan at the Annual Meeting held on May 20, 2025, authorizing the issuance of up to 15,722,908 shares under the plan.

Cardlytics reports an 8% year-over-year decrease in revenue for Q1 2025, alongside a 7% decrease in billings, but highlights progress in key business pillars.

Cardlytics, Inc. announces the non-renewal of its agreement with Bank of America, while also securing an extension to its loan facility with Banc of California.

Cardlytics announces its Q4 and full year 2024 financial results, highlighting a challenging year but expressing confidence in a return to growth and positive Adjusted EBITDA in 2025.

Cardlytics reported third quarter 2024 financial results, with revenue decreasing by 15% year-over-year, although results exceeded the high end of guidance.

Cardlytics, Inc. has appointed Srishti Gupta as a new director and member of the nominating and corporate governance committee, effective October 30, 2024.

Cardlytics, Inc. has entered into an amended and restated loan agreement with Banc of California, consolidating previous agreements into a single document.

Cardlytics has appointed Amit Gupta as its new CEO, effective August 16, 2024, and disclosed his compensation package including salary, bonuses, and stock options.

Cardlytics reported a mixed second quarter with revenue declining 9% year-over-year, while also announcing a CEO transition with Amit Gupta succeeding Karim Temsamani.

Cardlytics held its 2024 annual meeting where shareholders elected two Class III directors, ratified the selection of Deloitte & Touche LLP as the company's auditor, and approved executive compensation on an advisory basis.

Cardlytics announced its first quarter 2024 financial results, showing revenue growth and improved adjusted EBITDA, but also a net loss.

Cardlytics has appointed Liane Hornsey to its Board of Directors and Compensation Committee, with her set to become the Compensation Committee Chairperson after the upcoming annual meeting.

Cardlytics finalized a private offering of $172.5 million in convertible senior notes due 2029 and used a portion of the proceeds to repurchase $183.9 million of its 2025 notes.

Cardlytics, Inc. successfully completed a $50 million at-the-market offering by selling 3,907,600 shares of its common stock.

Cardlytics has established an agreement to potentially sell up to $50 million of its common stock through an at-the-market offering.

Cardlytics has entered into an agreement with American Express to provide access to its marketing platform for card-linked offers.